|
Market Closed -
Other stock markets
|
Pre-market 09:49:00 | |||
| 9.194 EUR | -1.92% |
|
9.298 | +1.13% |
| 04-20 | European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading | MT |
| 04-16 | Grifols receives FDA approval for its malaria blood screening assay | RE |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 11.53x | 1.04x | 0.33x | 1.81x | 7.23x | 9.56x | 2.1% | 6.75B | |
| 19.19x | 2.23x | -3.15x | 4.36x | 13.12x | 13.44x | 0.52% | 76.69B | |
| 26.98x | 3.81x | 2.31x | 5.38x | 15.52x | 19.56x | 0.59% | 55.29B | |
| 38.67x | 7.9x | 0.71x | 13.03x | 23.84x | 28.35x | -.--% | 49.73B | |
| 35.64x | 2.44x | -0.64x | 3.55x | 10.27x | 11.67x | 2.99% | 47.08B | |
| 15.62x | 1.35x | 0.44x | 2.94x | 8.82x | 9.69x | -.--% | 27.29B | |
| -7.49x | 3.39x | 28.42x | 8.45x | -6.22x | -5.9x | -.--% | 21.51B | |
| 15.5x | 2.87x | -4.9x | 2.51x | 7.89x | 7.52x | -.--% | 19.15B | |
| 24.4x | 3.38x | 0.02x | 4.94x | 13.47x | 17.98x | -.--% | 15.53B | |
| -39.08x | -6.27x | 0.81x | 17.63x | -49.18x | -58.01x | -.--% | 14.77B | |
| 74.04x | 29.32x | 0.84x | 38.09x | 51.76x | 52.74x | 0.09% | 13.36B | |
| 12.71x | - | 0.09x | 3.03x | 13.18x | 19.7x | -.--% | 10.5B | |
| -208.62x | 59.01x | 2.74x | 9.33x | 216.69x | -213.14x | -.--% | 9.36B | |
| 34.27x | - | 2.1x | - | - | - | -.--% | 8.03B | |
| 80.07x | 5.66x | -1.03x | - | - | - | - | 7.55B | |
| -148.55x | - | 9.84x | - | - | - | -.--% | 7.25B | |
| 34.33x | - | 0.43x | 8.88x | 26.58x | 32.73x | 0.28% | 5.6B | |
| 20.21x | 1.08x | 1.21x | - | - | - | 1.59% | 5.44B | |
| -11.66x | 1.16x | 0.05x | 2.23x | -21.45x | -21.86x | 0.48% | 5.35B | |
| Average | 1.46x | 7.89x | 2.14x | 8.41x | 22.10x | -5.06x | 0.48% | 21.38B | |
| Weighted average by Cap. | 15.31x | 5.39x | 1.39x | 7.40x | 16.44x | 7.47x | 0.61% |
- Stock Market
- Equities
- GRF Stock
- Sector Grifols, S.A.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition